Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,065,743
+$561,210 QoQ
Shares Held
2,556
-6.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#2,108
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. LLY ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,065,743 | 2,556 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,504,533 | 2,723 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,591,053 | 2,411 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,764,056 | 2,312 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,890,360 | 2,425 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $2,011,916 | 2,436 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,819,604 | 2,357 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,833,236 | 3,198 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,690,789 | 2,972 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,340,103 | 3,008 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,795,393 | 3,080 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,582,922 | 2,947 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,756,799 | 3,746 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,326,974 | 3,864 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,458,604 | 3,987 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,265,591 | 3,914 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $1,269,684 | 3,916 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $1,078,183 | 3,765 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $804,076 | 2,911 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $634,925 | 2,748 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $606,162 | 2,641 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $493,391 | 2,641 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $445,737 | 2,640 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $406,314 | 2,745 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $449,032 | 2,735 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $407,143 | 2,935 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||